KennethJohnColleyMDPhD(He/Him)
Internal Medicine • Santa Barbara, CAClinical Pharmacology
Exec Medical Director | Clinical Development | Translational and Integrative Medicine | Biotech and Wellness Entrepreneur
Dr. Colley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
27 W Anapamu St
Ste 448
Santa Barbara, CA 93101
Summary
- linkedin.com/in/drkencolley/
Education & Training
Johns Hopkins UniversityInternship, Internal Medicine, 1996 - 1997
Georgetown University School of MedicineClass of 1996
Certifications & Licensure
CA State Medical License 1999 - 2026
MD State Medical License 1997 - 1998
Publications & Presentations
PubMed
- 11 citationsPhase I study in healthy participants to evaluate safety, tolerability, and pharmacokinetics of inhaled nezulcitinib, a potential treatment for COVID-19.Nathan D. Pfeifer, Arthur Lo, David L. Bourdet, Kenneth Colley, Dave Singh
Clinical and Translational Science. 2021-08-31 - 22 citationsLipoprotein-associated phospholipase A2: role in atherosclerosis and utility as a cardiovascular biomarkerPeter P. Toth, Peter A. McCullough, Michael S Wegner, Kenneth J Colley
Expert Review of Cardiovascular Therapy. 2010-03-01 - 47 citationsPleiotrophin induces formation of functional neovasculature in vivoKaren L. Christman, Qizhi Fang, Anne J. Kim, Richard E. Sievers, Hubert H. Fok
Biochemical and Biophysical Research Communications. 2005-07-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
